Safety and Tolerability of Lixisenatide in Combination With Oral Anti-Diabetic Treatment in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
Primary Objective:
The primary objective of this study is to assess the overall safety of lixisenatide once
daily treatment in combination with background oral anti-diabetic treatment over 52 weeks in
patients with type 2 diabetes in Japan.
Secondary Objective:
To assess the effects of lixisenatide in combination with background oral antidiabetic drug
(OAD) on:
- HbA1c;
- Fasting plasma glucose;
- Body weight.